tiprankstipranks
Trending News
More News >
Avalo Therapeutics (AVTX)
NASDAQ:AVTX

Avalo Therapeutics (AVTX) Revenue

Compare
906 Followers

Avalo Therapeutics Revenue

Avalo Therapeutics had a revenue of 192.00K in the quarter ending Dec 31, 2024, with -22.89%. This bring the company's revenue in the last twelve months to 441.00K, Increased -46.22%. In the fiscal year ending Dec 31, 2024, Avalo Therapeutics had annual revenue of 441.00K with -77.08% growth.
Revenue (ttm)
441.00K
Revenue Growth
-77.09%
P/S Ratio
130.19
Revenue/Employee
$19,174
Employees
23
Market Cap
$57.42M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024441.00K-1.48M-77.08%
Dec 31, 20231.92M-16.13M-89.34%
Dec 31, 202218.05M12.65M+234.40%
Dec 31, 20215.40M-1.30M-19.42%
Dec 31, 20206.70M-51.00K-0.76%
Dec 31, 20196.75M-11.58M-63.17%
Dec 31, 201818.33M-9.49M-34.11%
Dec 31, 201727.81M26.66M+2,312.24%
Dec 31, 20161.15M+∞%
Dec 31, 20150.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis